BioPorto A/S (CPH:BIOPOR)
Denmark · Delayed Price · Currency is DKK 1.020
-0.020 (-1.92%)
Dec 30, 2025, 4:59 PM CET
BioPorto Market Cap
BioPorto has a market cap or net worth of 505 million as of December 31, 2025. Its market cap has decreased by -32.84% in one year.
Market Cap
505.00M
Enterprise Value
485.74M
Revenue
36.56M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.02
Market Cap Chart
Since March 1, 2005, BioPorto's market cap has increased from 75.28M to 505.00M, an increase of 570.84%. That is a compound annual growth rate of 9.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 30, 2025 | 505.00M | -24.17% |
| Dec 30, 2024 | 665.97M | -16.07% |
| Dec 29, 2023 | 793.48M | 2.41% |
| Dec 30, 2022 | 774.78M | 17.16% |
| Dec 30, 2021 | 661.32M | -38.59% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.45T |
| Genmab | 124.86B |
| Coloplast | 123.14B |
| ALK-Abelló | 50.52B |
| Demant | 45.84B |
| H. Lundbeck | 41.33B |
| Zealand Pharma | 32.85B |
| Ambu A/S | 23.42B |